» Articles » PMID: 12975385

Organ-specific Overexpression of Renal LAT2 and Enhanced Tubular L-DOPA Uptake Precede the Onset of Hypertension

Overview
Journal Hypertension
Date 2003 Sep 17
PMID 12975385
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Spontaneously hypertensive rats (SHR) might have increased renal production of dopamine. L-3,4-Dihydroxyphenylalanine (L-DOPA) uptake in renal epithelial cells is promoted through the type 2 L-type amino acid transporter (LAT2), and this might rate-limit the synthesis of renal dopamine. The present study evaluated L-DOPA uptake in isolated renal proximal tubules of SHR and normotensive controls (Wistar-Kyoto rats [WKY]). Expression of LAT1 and LAT2 in the renal cortex and intestinal mucosa was also evaluated. Tubular uptake of L-DOPA in WKY and SHR was a saturable process, being greater in the latter than the former at both 4 and 12 weeks of age. cDNA fragments (LAT1, 688 bp; LAT2, 729 bp) labeled with 32P were used as probes for Northern blot analysis. Expression of LAT2 in SHR kidneys was higher than in WKY kidneys. This increase was more marked at 4 than at 12 weeks of age. Intestinal LAT2 expression, however, was identical in SHR and WKY at both 4 and 12 week of age. By Northern blot analysis, the LAT1 transcript was not identified in either the kidney or intestine. Kidney total RNA was then reverse-transcribed and amplified by polymerase chain reaction with specific primers for LAT1. The presence of a fragment of the expected size for LAT1 led to the conclusion that LAT1 mRNA is a rare message in kidney. We conclude that overexpression of LAT2 in the SHR kidney might contribute to the enhanced L-DOPA uptake, which is organ specific and precedes the onset of hypertension.

Citing Articles

Evidence for a relationship between genetic polymorphisms of the L-DOPA transporter LAT2/4F2hc and risk of hypertension in the context of chronic kidney disease.

Crocco P, Dato S, La Grotta R, Passarino G, Rose G BMC Med Genomics. 2024; 17(1):163.

PMID: 38890684 PMC: 11186288. DOI: 10.1186/s12920-024-01935-2.


Anti-Inflammatory Effects of Peripheral Dopamine.

Moore S, de Castro P, Yaqub D, Jose P, Armando I Int J Mol Sci. 2023; 24(18).

PMID: 37762126 PMC: 10530375. DOI: 10.3390/ijms241813816.


Identification of biomarkers, pathways, and potential therapeutic targets for heart failure using next-generation sequencing data and bioinformatics analysis.

Ganekal P, Vastrad B, Vastrad C, Kotrashetti S Ther Adv Cardiovasc Dis. 2023; 17:17539447231168471.

PMID: 37092838 PMC: 10134165. DOI: 10.1177/17539447231168471.


Cardiometabolic and Inflammatory Benefits of Sympathetic Down-Regulation with Zamicastat in Aged Spontaneously Hypertensive Rats.

Igreja B, Pires N, Loureiro A, Wright L, Soares-da-Silva P ACS Pharmacol Transl Sci. 2020; 2(5):353-360.

PMID: 32259069 PMC: 7089015. DOI: 10.1021/acsptsci.9b00039.


Gastrin stimulates renal dopamine production by increasing the renal tubular uptake of l-DOPA.

Jiang X, Zhang Y, Yang Y, Yang J, Asico L, Chen W Am J Physiol Endocrinol Metab. 2016; 312(1):E1-E10.

PMID: 27780818 PMC: 5283882. DOI: 10.1152/ajpendo.00116.2016.